Contract with Customer, Liability, Current of Ernexa Therapeutics Inc. from 31 Dec 2018 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Ernexa Therapeutics Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2018 to 31 Mar 2025.
  • Ernexa Therapeutics Inc. Contract with Customer, Liability, Current for the quarter ending 31 Mar 2025 was $5,335,000.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $5,335,000 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2020 $76,000 -$384,000 -83% 31 Dec 2020 10-K 11 Mar 2021 2020 FY
Q3 2020 $120,000 -$623,000 -84% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $377,000 -$141,000 -27% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $383,000 -$811,000 -68% 31 Mar 2020 10-Q 20 May 2020 2020 Q1
Q4 2019 $460,000 -$911,000 -66% 31 Dec 2019 10-K 19 Mar 2020 2019 FY
Q3 2019 $743,000 30 Sep 2019 10-Q 01 Nov 2019 2019 Q3
Q2 2019 $518,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $1,194,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $1,371,000 31 Dec 2018 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.